Your browser doesn't support javascript.
loading
Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee.
Kumar, Shaji; Baizer, Lawrence; Callander, Natalie S; Giralt, Sergio A; Hillengass, Jens; Freidlin, Boris; Hoering, Antje; Richardson, Paul G; Schwartz, Elena I; Reiman, Anthony; Lentzsch, Suzanne; McCarthy, Philip L; Jagannath, Sundar; Yee, Andrew J; Little, Richard F; Raje, Noopur S.
Afiliação
  • Kumar S; Hematologic Malignancies, Mayo Clinic College of Medicine and Science, Rochester, USA.
  • Baizer L; Division of Lung Diseases, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA. baizerl@mail.nih.gov.
  • Callander NS; Myeloma Clinical Program, University of Wisconsin Carbone Cancer Center, Madison, USA.
  • Giralt SA; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, Madison, USA.
  • Hillengass J; Oncology and Internal Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, USA.
  • Freidlin B; Biometric Research Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Hoering A; Cancer Research and Biostatistics and University of Washington School of Public Health, Seattle, USA.
  • Richardson PG; Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, USA.
  • Schwartz EI; Coordinating Center for Clinical Trials, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Reiman A; University of New Brunswick, Department of Medicine, Dalhousie University Department of Oncology, Saint John Regional Hospital, Fredericton, Canada.
  • Lentzsch S; Multiple Myeloma and Amyloidosis Service, Department of Medicine, Columbia University Medical Center, New York, USA.
  • McCarthy PL; Department of Medicine, Oncology and Internal Medicine, Transplant & Cellular Therapy Center, Roswell Park Comprehensive Cancer Center, Buffalo, USA.
  • Jagannath S; Division of Hematology and Medical Oncology, Mount Sinai School of Medicine, Center of Excellence for Multiple Myeloma, New York, USA.
  • Yee AJ; Department of Medicine, Harvard Medical School, Multiple Myeloma Program, Medical Oncology, Massachusetts General Hospital, Boston, USA.
  • Little RF; Clinical Investigations Branch, Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Raje NS; Department of Medicine, Harvard Medical School, Multiple Myeloma Program, Medical Oncology, Massachusetts General Hospital, Boston, USA.
Blood Cancer J ; 12(6): 98, 2022 06 29.
Article em En | MEDLINE | ID: mdl-35768410
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Mieloma Múltiplo Tipo de estudo: Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article